The Quality of Well-being Scale is an interviewer-administrated measure of health-related quality of life. The measure has been used in a wide variety of outcome and public policy studies. A major feature of the measure is that it can be used for cost-utility analysis. There have been at least three criticism of the QWB for outcome studies in arthritis. First, the QWB must be administered by an interviewer. Second, the QWB has not been validated specifically for patients with arthritis. Third, the preference weighting system is based on the general population rather than arthritis patients. The QWB has recently been redeveloped as a self-administered questionnaire (QWB-SA). The purpose of the study is to validate the QWB-SA for patients with arthritis and musculoskeletal disorders. This study has four Specific Aims.
The first Aim i s to demonstrate the feasibility of the QWB-SA for patients with arthritis and musculoskeletal disorders. The QWB-SA will be administered along with the AIMS-2 and the SF-36 to 1,500 patients. Analysis will consider rates of completed responses, difference in response, and missing information. The second Specific Aim is to develop an arthritis-specific QWB-SA. This will be accomplished by analyzing data collected in relation to Specific Aim 1. Comparisons between arthritis and non patients, using item analysis, will identify components of the measure that separate arthritis patients from patients with other illnesses.
The third Aim i s to compare preferences from arthritis patients and non patients. This will be accomplished by obtaining ratings for case descriptions and analyzing whether patients have different preference for outcome that non patients. The fourth Specific Aim will be to determine whether patients have different preference for outcome when in acute or non acute pain states. This study will use 100 Rheumatoid Arthritis patients. Half the patients will enter the study when in acute flare while the others will enter when they are not in an acute state. Both groups will be followed prospectively. The product of the research would be an improved outcome measure for public policy studies relevant to arthritis.

Project Start
2000-03-01
Project End
2002-02-28
Budget Start
Budget End
Support Year
9
Fiscal Year
2000
Total Cost
$112,459
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Malcarne, Vanessa L; Hansdottir, Ingunn; McKinney, Ann et al. (2007) Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol 34:359-67
Leake, John A D; Albani, Salvatore; Kao, Annie S et al. (2004) Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 23:756-64
Meyer, Markus; Belke, Darrell D; Trost, Susanne U et al. (2004) A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation. FASEB J 18:1312-4
Groessl, Erik J; Kaplan, Robert M; Cronan, Terry A (2003) Quality of well-being in older people with osteoarthritis. Arthritis Rheum 49:23-8
Kaplan, Robert M (2003) The significance of quality of life in health care. Qual Life Res 12 Suppl 1:3-16
Johnson, Kristen; Goding, James; Van Etten, Deborah et al. (2003) Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res 18:994-1004
La Cava, Antonio; Massa, Margherita; Mendivil, Alberto et al. (2002) Genetic immunization maps T cell (auto)immune responses to self antigens homologous to exogenous proteins. Autoimmunity 35:105-10
Prakken, Berent J; Roord, Sarah; van Kooten, Peter J S et al. (2002) Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arthritis Rheum 46:1937-46
Kaplan, Robert M (2002) Quality of life: an outcomes perspective. Arch Phys Med Rehabil 83:S44-50
Silverman, Gregg J; Goodyear, Carl S (2002) A model B-cell superantigen and the immunobiology of B lymphocytes. Clin Immunol 102:117-34

Showing the most recent 10 out of 94 publications